Xiaoli Du, PhD

Dr. Du’s work has focused on the genetic basis of oncology. She received her PhD in cancer cell biology from Peking Union Medical College where she identified the new biomarkers for early stage esophageal cancer and functionally tested novel variants overexpressing in patients with esophageal cancer. As a postdoctoral fellow in Dr. Douglas R. Lowy’s lab at the National Cancer Institute (NCI) of the National Institutes of Health (NIH), she continued her research in the molecular mechanisms of tumor suppressor gene in lung cancer carcinogenesis. Dr. Du joined Cincinnati Children's Hospital Medical Center in the summer of 2018 as a fellow in the Laboratory Genetics and Genomics training program. She is training in implementation and interpretation of both molecular and cytogenetic diagnostic tests, as well as the development and validation of novel assays for use in clinical settings.